Warfield, Kelly L.
Plummer, Emily M.
Sayce, Andrew C.
Alonzi, Dominic S.
Tang, William
Tyrrell, Beatrice E. https://orcid.org/0000-0003-2912-6419
Hill, Michelle L.
Caputo, Alessandro T.
Killingbeck, Sarah S.
Beatty, P. Robert
Harris, Eva
Iwaki, Ren
Kinami, Kyoko
Ide, Daisuke
Kiappes, J.L.
Kato, Atsushi
Buck, Michael D.
King, Kevin
Eddy, William
Khaliq, Mansoora
Sampath, Aruna
Treston, Anthony M.
Dwek, Raymond A.
Enterlein, Sven G.
Miller, Joanna L.
Zitzmann, Nicole
Ramstedt, Urban
Shresta, Sujan
Funding for this research was provided by:
NIAID (HHSN272201100030C)
Oxford Glycobiology Institute Endowment
Emergent BioSolutions
Lerner-Fink Fellowship
Wellcome Trust (097300/Z/11/Z)
Wellcome Trust (105402/Z/14/Z)
Institutional Animal Care and Use Committee (AP028-SS1-0615)
UC Berkeley (R252-1012B)
NHS National Research Ethics Service (09/H0606/3)
This article is maintained by: Elsevier
Article Title: Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
Journal Title: Antiviral Research
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.antiviral.2016.03.001
Content Type: article
Copyright: Copyright © 2016 The Authors. Published by Elsevier B.V.